HopeStage
Back to all studies
CompletedNCT02717195

Lu AF35700 for Treatment-Resistant Schizophrenia Symptoms

About this titleRead the official source — NCT02717195
Medication studyAges 18+Multiple countries
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
Bellflower and 146 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2016
Recruitment status
Completed
Enrollment listed in the registry
1,098
Sponsor
H. Lundbeck A/S
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada, Bulgaria, ...
Age range
Over 18 Years
Official registry ID
NCT02717195
Official title
Show the full official title

Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bellflower, United States · Cerritos, United States · Costa Mesa, United States

110 more locations
  • Culver City, United States
  • Garden Grove, United States
  • Glendale, United States
  • National City, United States
  • Oceanside, United States
  • Orange, United States
  • San Bernardino, United States
  • Santa Ana, United States
  • Sherman Oaks, United States
  • Torrance, United States
  • Washington D.C., United States
  • Bradenton, United States
  • Jacksonville, United States
  • Miami, United States
  • North Miami, United States
  • Oakland Park, United States
  • Orange City, United States
  • Tampa, United States
  • Atlanta, United States
  • Decatur, United States
  • Chicago, United States
  • Hoffman Estates, United States
  • Shreveport, United States
  • Flowood, United States
  • Las Vegas, United States
  • Berlin, United States
  • Marlton, United States
  • Glen Oaks, United States
  • Jamaica, United States
  • New York, United States
  • Rochester, United States
  • Staten Island, United States
  • Charlotte, United States
  • Hickory, United States
  • Norristown, United States
  • Charleston, United States
  • Austin, United States
  • Dallas, United States
  • Fort Worth, United States
  • Burgas, Bulgaria
  • Kazanlak, Bulgaria
  • Lovech, Bulgaria
  • Pazardzhik, Bulgaria
  • Plovdiv, Bulgaria
  • Sofia, Bulgaria
  • Tserova Koria, Bulgaria
  • Varna, Bulgaria
  • Veliko Tarnovo, Bulgaria
  • Vratsa, Bulgaria
  • Chatham, Canada
  • Kingston, Canada
  • Montreal, Canada
  • Penticton, Canada
  • Québec, Canada
  • Brno, Czechia
  • Hostivice, Czechia
  • Lnáře, Czechia
  • Prague, Czechia
  • Pärnu, Estonia
  • Tallinn, Estonia
  • Viljandi, Estonia
  • Espoo, Finland
  • Kuopio, Finland
  • Turku, Finland
  • Durango, Mexico
  • Guadalajara, Mexico
  • México, Mexico
  • Monterrey, Mexico
  • San Luis Potosí City, Mexico
  • Bełchatów, Poland
  • Bialystok, Poland
  • Gorlice, Poland
  • Lodz, Poland
  • Lublin, Poland
  • Pruszcz Gdański, Poland
  • Pruszków, Poland
  • Torun, Poland
  • Wroclaw, Poland
  • Bucharest, Romania
  • Campulung Muscel, Romania
  • Sibiu, Romania
  • Târgu Mureş, Romania
  • Nikol’skoye, Russia
  • Arkhangelsk, Russia
  • Moscow, Russia
  • Saint Petersburg, Russia
  • Yaroslavl, Russia
  • Belgrade, Serbia
  • Kragujevac, Serbia
  • Niš, Serbia
  • Novi Kneževac, Serbia
  • Bratislava, Slovakia
  • Rožňava, Slovakia
  • Svidník, Slovakia
  • Zlaté Moravce, Slovakia
  • Barcelona, Spain
  • Madrid, Spain
  • Málaga, Spain
  • Oviedo, Spain
  • Zamora, Spain
  • Dnipropetrovsk, Ukraine
  • Kharkiv, Ukraine
  • Kherson, Ukraine
  • Kiev, Ukraine
  • Lviv, Ukraine
  • Odesa, Ukraine
  • Poltava, Ukraine
  • Vinnitsa, Ukraine
  • Czechia
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is H. Lundbeck A/S.

Did this study involve medication?

Yes. The study involved medication, including Risperidone, Olanzapine and Lu AF35700.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies